H.R. 1271 · 115th Congress
DXM Abuse Prevention Act of 2017
- Stage
- In committee
- Sponsor
- Bill Johnson
- Introduced
- 2017-03-01
- Latest action
- 2017-03-17 · Referred to the Subcommittee on Health.
Summary
DXM Abuse Prevention Act of 2017
This bill amends the Federal Food, Drug, and Cosmetic Act to: (1) require a retailer that sells certain drugs containing dextromethorphan (DXM) to have a verification system that is intended to ensure that no one under 18 years of age purchases such drugs from the retailer, (2) establish other restrictions on the sale of over-the-counter drugs containing DXM, and (3) establish restrictions on the distribution of bulk DXM.